S.Korea authorises AstraZeneca COVID therapy Evusheld for vulnerable people
SEOUL – South Korea on Thursday authorised AstraZeneca PLC’s antibody-based therapy for preventing COVID-19 infection in people with a poor immune response, increasing its options as it works to ease the pandemic…